Journal of Hematology & Thrombosis

Editorial Board

Editor-in-Chief
Dr. Roy E. Smith
Dr. Roy E. Smith

is a Professor of Medicine, Division of Hematology-Oncology at University of Pittsburgh, USA. He served as the Director of Hematology Fellowship Training Program, Clinical Coagulation Service and OSU Hemophilia Center. His research interests are Colorectal Cancer Bleeding & Thrombotic Disorders.

Dr. Guido J. K. Tricot
Dr. Guido J. K. Tricot

is the Director of Adult Hematopoietic Stem Cell Transplantation & Multiple Myeloma, University of Iowa Hospital & Clinics, USA. He was the Director of Bone Marrow Transplantation & the Myeloma program, University of Utah. His Research interests are Multiple Myeloma, more specifically myeloma stem cell research.

Dr. Khalid Matin
Dr. Khalid Matin

is the Medical Director of Community Oncology & Clinical Research Affiliations and an Associate Professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, VCU School of Medicine, USA. He is an expert in the study and treatment of GI cancers.

Dr. Raul H. Morales-Borges
Dr. Raul H. Morales-Borges

is the Medical Director, American Red Cross in San Juan, Practices, Ashford Institute of Hematology & Oncology and also a Faculty of the Ashford Presbyterian Community Hospital, USA. His research interests are anemia & coagulation in pregnancy and elderly, transfusion medicine, therapeutic aphaeresis, breast and GI oncology.

Dr. Kerry Hitos
Dr. Kerry Hitos

is the Executive Director of the Westmead Research Centre for the Evaluation of Surgical Outcomes in the Department of Surgery, University of Sydney, Australia. Her research focuses on the prevention and treatment of venous thromboembolism and cancer as well as the epidemiological, clinical and pathophysiological aspects of diseases.

Dr. Tahir Latif
Dr. Tahir Latif

is the Interim Director for the Division of Hematology/Oncology, University of Cincinnati, USA. His research interests are Lymphoma, CNS involvement by Lymphoma, quality improvement and outcome research. He has developed a successful practice in Cincinnati and is instrumental in developing several key quality and performance improvement initiatives.

Dr. Jamie Case
Dr. Jamie Case

is the Scientific Program Director of Bio-Repository and Transplantation Research, Scripps Center for Organ & Cell Transplantation, Scripps Clinic Medical Group, La Jolla, USA. He has vast experience and a broad background in the field of stem cell biology (hematopoietic and endothelial progenitor cells) and angiogenesis.

Dr. Preet M. Chaudhary
Dr. Preet M. Chaudhary

is a Professor and Chief of the Jane Ann Nohl Division of Hematology and Blood Diseases, Keck School of Medicine of USC, USA. His research interests in hematopoietic stem cell transplant, AIDS associated malignancies, NF-kB signaling, cell death and chimeric antigen receptor based cellular therapy.

Dr. Elias Anaissie
Dr. Elias Anaissie

is the Chief of the Heme-Malignancies and BMT Program at the University of Cincinnati Cancer Institute, USA. His research interests include improving the outcome of patients with hematologic cancers and hematopoietic stem cell transplant recipients, infections, graft versus host disease, antineoplastic chemotherapy and stem cell transplantation.

Dr. Ferdane Kutlar
Dr. Ferdane Kutlar

is a Professor of Medicine and Director of the Sickle Cell Center’s Titus HJ Huisman Hemoglobinopathy & Diagnostic DNA Laboratory, Georgia Regents University, USA. She has developed and implemented DNA based tests to identify hemoglobinopathies and to elucidate the role of genetic modifiers of Sickle Cell Disease.

Dr. Xiao-Feng Yang
Dr. Xiao-Feng Yang

is a Professor of Pharmacology, Immunology, Cardiovascular Research and also at the Centers for Metabolic Disease Research and Thrombosis Research in the Departments of Pharmacology, Microbiology, and Immunology, Temple University School of Medicine, USA. His research interests focuses on studying the regulatory mechanisms of immune responses.

Dr. Paolo Prandoni
Dr. Paolo Prandoni

is a Professor in the Department of Medicine, Thromboembolism Unit at the University of Padua, Italy. His research interests cover the epidemiology, diagnosis & management of thromboembolism, focusing on association of cancer with venous thromboembolism.

Dr. Clark William Distelhorst
Dr. Clark William Distelhorst

is a Professor of Hematology/Oncology, Case Western Reserve University, USA. His research focuses on Bcl-2 protein family, apoptosis, autophagy, signal transduction by intracellular calcium ions, developed a decoy peptide that inhibits Bcl-2-IP3R interaction, inducing Ca2+ elevation and apoptosis in CLL, myeloma, lymphoma & small cell lung cancer.

Dr. M. James You
Dr. M. James You

is an Associate Professor of the Department of Hematopathology, University of Texas MD Anderson Cancer Center, USA. He has expertise in the diagnosis of Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders and Multiple Myeloma. His research focuses on genetic modeling and translation aspect of leukemia and lymphoma.

Dr. Ken He Young
Dr. Ken He Young

is a Professor in the Department of Hematopathology at University of Texas MD Anderson Cancer Center, USA. He is board certified in Anatomic, Clinical Pathology & Pathology-Hematology. He has special expertise in B-Cell Lymphoma, Chronic B-Cell Lymphocytic Leukemia, Mantle-Cell Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders.

Dr. Ryuji Hamamoto
Dr. Ryuji Hamamoto

is an Associate Professor of Medicine, University of Chicago, USA. His research works in the field of cancer epigenetics and he has been studying physiological and biological significance of protein methylation in human tumorigenesis, in particular focusing on the histone methylation, which is involved in human cancer.

Dr. Anna Martner
Dr. Anna Martner

is an Associate Professor and Group Leader at Sahlgrenska Cancer Center, University of Gothenburg, Sweden. She has experience from research on various aspects of immunology and immunoregulation. Her current research focuses on translational studies in acute and chronic myeloid leukemia.

Dr. Neerja Vajpayee
Dr. Neerja Vajpayee

is an Associate Professor of Hematopathology, SUNY Upstate Medical University, USA. Her research interests are neoplastic hematological diseases, specifically Non Hodgkin lymphoma and myeloma. She is interested in clincopatholgical correlation and non-neoplastic hematological diseases including bleeding & coagulation disorders.

Dr. Catherine Ross
Dr. Catherine Ross

is an Associate Professor of Department of Pathology & Molecular Medicine, Hamilton Health Sciences, Canada. Her research interests include lymphoma diagnosis and prognosis, as well as myelopliferative neoplasms and also she has an interest in emerging applications of 10 colour flow cytometry such as minimal residual disease.

Dr. Arlynn F. Mulne
Dr. Arlynn F. Mulne

is an Associate Professor in the Department of Pediatrics, Division of Hematology/Oncology at the Texas Tech University Health Sciences Center (TTUHSC) at El Paso, USA. Her research interests focuses on Neuro Oncology.

Dr. Yi Wu
Dr. Yi Wu

is an Assistant Professor in Sol Sherry Thrombosis Research Center at Temple University School of Medicine, USA. His Research includes initiation mechanism of thrombosis, signal transduction of platelet receptor activation & coagulation pathway, Physiological & pathophysiological functions of plasma kallikrein-kinin system and Phosphatidylserine regulation of innate immunity.

Dr. Kamal Kant Singh Abbi
Dr. Kamal Kant Singh Abbi

is an Assistant Professor in the Division of Hematology, Oncology and Blood & Marrow transplantation at Department of Internal Medicine, University of Iowa Hospitals and Clinics, USA. His main research interest includes: Hematological malignancies especially multiple myeloma and Bone Marrow Transplantation.

Dr. James J. Driscoll
Dr. James J. Driscoll

is an Assistant Professor of Medicine in the Division of Hematology & Oncology at the University of Cincinnati, USA. His research focuses on the therapeutically targeting the ubiquitin & proteasome system in hematologic malignancies. The long-term goal is to uncover new targets that can serve as novel diagnostic biomarkers and more effective therapeutics to treat human cancers.

Dr. Natalia Beglova
Dr. Natalia Beglova

is an Assistant Professor of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, USA. Her research focuses on molecular mechanisms of thrombosis with antiphospholipid syndrome; using multidisciplinary approaches to understanding how b2GPI/antibody complexes interact with anionic phospholipids & cellular receptors causing thrombosis.

Dr. Olalekan Oluwole
Dr. Olalekan Oluwole

is an Assistant Professor of Medicine in Hematology/Oncology, Vanderbilt University, USA. His research focuses on Chronic Lymphocytic Leukemia, Hodgkin & non Hodgkin lymphomas and using clinical trials targeted therapies aimed at improving treatment outcomes in patients with hematologic malignancies.

Dr. Jeremy Pantin
Dr. Jeremy Pantin

is an Assistant Professor at Georgia Regents University, USA. His research interests include immune tolerance and graft-versus-host disease. His original work was presented at national meetings of the American Society of Hematology and the American Society for Blood and Marrow Transplantation.

Dr. Amy Lowery
Dr. Amy Lowery

is an Assistant Professor of Medicine in the Division of Hematology/Oncology at University of Pittsburgh, USA. She is a clinical psychologist at UPMC Cancer Center & also an active member of the Society of Behavioral Medicine, National Comprehensive Cancer Network, American Academy of Sleep Medicine, Sleep Research Society & Behavioral Sleep Medicine Society.

Dr. Soham D. Puvvada
Dr. Soham D. Puvvada

is an Assistant Professor of Medicine in the Division of Hematology/Oncology at University of Arizona Cancer Center, USA. Her research interests include lymphoma in both Hodgkins and non-Hodgkin’s, T cell lymphoma, Cutaneous T cell lymphoma, genomics, phase I and early clinical trial development.

Dr. Zartash Gul
Dr. Zartash Gul

is an Assistant Professor of Internal Medicine in the Division of Hematology/Oncology and Bone Marrow Transplantation at University of Kentucky, USA. Her main research interest includes Hematologic Malignancies, Bone Marrow Transplantation and Cord Blood Transplantation.

Dr. Elisa Boscolo
Dr. Elisa Boscolo

is an Assistant Professor, UC Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, USA. She currently investigates cell based strategies to model vascular anomalies, progression, with the goal of discovering novel efficient treatments to normalize the pathological vasculature, they are infantile hemangioma, venous malformation and lymphatic malformation.

Dr. Laura R. Goldberg
Dr. Laura R. Goldberg

is an Assistant Professor in Hematology/Oncology at Warren Alpert Medical School of Brown University, USA. Her research interests focuses on translational science within the field of hematopoietic stem cell biology with a primary focus on defining the total population of long-term multi-lineage renewal marrow stem cells in WBM.

Dr. Yvonne Adeduni Efebera
Dr. Yvonne Adeduni Efebera

is an Assistant Professor of Medicine in the Division of Hematology at The Ohio State University, USA. Her special research interests are in Multiple Myeloma, Amyloidosis, Blood and marrow transplantation and Graft-versus-Host-disease.

Dr. Katherine Walsh
Dr. Katherine Walsh

is an Assistant Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University, USA. Her clinical work focuses on patients with cytopenias and myeloproliferative disorders. She also holds leadership roles within the medical school clinical curriculum and has research interests in promoting bedside teaching and direct observation of students.

Dr. Etsuko Matsubara
Dr. Etsuko Matsubara

is an Assistant Professor, Department of Hematology, Ehime University Graduate School of Medicine, Japan. Her research interests in Anemia, Acute Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Malignant Lymphoma, Hematopoietic Stem Cell Transplantation and Infections in Immunocompromised Patients.

Dr. Agata Sobczyska – Malefora
Dr. Agata Sobczyska – Malefora

is a Principal Clinical Scientist at The Human Nutristasis Unit, St. Thomas’ Hospital, London. Her research focuses on one carbon metabolism, hyperhomocysteinaemia, utility of markers for vitamin B12 & folate status and oral anticoagulation in relation to cardiovascular and AD & diseases which affect the absorption of B vitamins.

Dr. Libor Cervinek
Dr. Libor Cervinek

is a Clinical Hematologist and works for the Department of Hematology and Oncology at University Hospital Brno and Masaryk University School of Medicine, Czech Republic. His research interest focuses on chronic immune heamatologic diseases (immune thrombocytopenic purpura, paroxysmal nocturnal hemoglobinuria), myelody plastic syndromes and myeloproliferative disorders.

Dr. Athanasios Tragiannidis
Dr. Athanasios Tragiannidis

is a Lecturer of Pediatric Hematology in the Aristotle University of Thessaloniki, Greece. He was nominated specialist in Pediatrics at the University of Thessaloniki, Greece. Among his major topics of interest, acute myeloid leukemia, MDS, invasive fungal infections and late effects of chemotherapy are included.